Natural history and retinal structure in patients with Usher syndrome type 1 owing to MYO7A mutation

Ophthalmology. 2014 Feb;121(2):580-7. doi: 10.1016/j.ophtha.2013.09.017. Epub 2013 Nov 5.

Abstract

Purpose: To evaluate the phenotypic variability and natural history of ocular disease in a cohort of 28 individuals with MYO7A-related disease. Mutations in the MYO7A gene are the most common cause of Usher syndrome type 1, characterized by profound congenital deafness, vestibular arreflexia, and progressive retinal degeneration.

Design: Retrospective case series.

Participants: Twenty-eight patients from 26 families (age range, 3-65 years; median, 32) with 2 likely disease-causing variants in MYO7A.

Methods: Clinical investigations included fundus photography, optical coherence tomography, fundus autofluorescence (FAF) imaging, and audiologic and vestibular assessments. Longitudinal visual acuity and FAF data (over a 3-year period) were available for 20 and 10 study subjects, respectively.

Main outcome measures: Clinical, structural, and functional characteristics.

Results: All patients with MYO7A mutations presented with features consistent with Usher type 1. The median visual acuity for the cohort was 0.39 logarithm of the minimum angle of resolution (logMAR; range, 0.0-2.7) and visual acuity in logMAR correlated with age (Spearman's rank correlation coefficient, r = 0.71; P<0.0001). Survival analysis revealed that acuity ≤ 0.22 logMAR was maintained in 50% of studied subjects until age 33.9; legal blindness based on loss of acuity (≥ 1.00 logMAR) or loss of field (≤ 20°) was reached at a median age of 40.6 years. Three distinct patterns were observed on FAF imaging: 13 of 22 patients tested had relatively preserved foveal autofluorescence surrounded by a ring of high density, 4 of 22 had increased signal in the fovea with no obvious hyperautofluorescent ring, and 5 of 22 had widespread hypoautofluorescence corresponding to retinal pigment epithelial atrophy. Despite a number of cases presenting with a milder phenotype, there seemed to be no obvious genotype-phenotype correlation.

Conclusions: MYO7A-related ocular disease is variable. Central vision typically remains preserved at least until the third decade of life, with 50% of affected individuals reaching legal blindness by 40 years of age. Distinct phenotypic subsets were identified on FAF imaging. A specific allele, previously reported in nonsyndromic deafness, may be associated with a mild retinopathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Female
  • Fluorescein Angiography
  • Genetic Association Studies
  • Hearing Loss, Sensorineural / diagnosis
  • Hearing Tests
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Myosin VIIa
  • Myosins / genetics*
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Usher Syndromes / diagnosis*
  • Usher Syndromes / genetics*
  • Vestibular Function Tests
  • Visual Acuity / physiology
  • Visual Field Tests
  • Young Adult

Substances

  • MYO7A protein, human
  • Myosin VIIa
  • Myosins